Drug Interactions and Side Effects Analysis of Zyprexa and Geodon and Depakote and Serzone and Zoloft and Effexor and Ambien and Synthroid and Temazepam and Hydrocodone Bitartrate and Livostin and Trileptal and Trimox and Sonata and Lotensin and Abilify and Flomax and Pravachol
>>> Check drugs in a new way
| Report ID | Date of report | Patient age | Patient gender |
| 75046 | Mar, 2, 2006 | 46 | Male |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Zyprexa | olanzapine |
Geodon | ziprasidone hydrochloride |
Depakote | divalproex sodium |
Serzone | nefazodone hydrochloride |
Zoloft | sertraline hydrochloride |
Effexor | venlafaxine hydrochloride |
Ambien | zolpidem tartrate |
Synthroid | levothyroxine sodium |
Temazepam | temazepam |
Hydrocodone Bitartrate | hydrocodone bitartrate; ibuprofen |
Livostin | levocabastine hydrochloride |
Trileptal | oxcarbazepine |
Trimox | amoxicillin |
Sonata | zaleplon |
Lotensin | benazepril hydrochloride |
Abilify | aripiprazole |
Flomax | tamsulosin hydrochloride |
Pravachol | pravastatin sodium |
| Name |
Diabetes Mellitus Non-insulin-dependent |
Diabetic Coma |
Haemorrhoids |
Hypertension |
Increased Appetite |
Nephrolithiasis |
Rectal Haemorrhage |
Treatment Noncompliance |
Results from eHealthMe : 2 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Diabetes Mellitus Non-insulin-dependent | 2 (100.00%) |
Diabetic Coma | 2 (100.00%) |
Haemorrhoids | 2 (100.00%) |
Hypertension | 2 (100.00%) |
Increased Appetite | 1 (50.00%) |
Nephrolithiasis | 2 (100.00%) |
Rectal Haemorrhage | 2 (100.00%) |
Treatment Noncompliance | 2 (100.00%) |
Top 3 (total: 0. Click here to see more) co-used drugs - potential interacting drugs:
Death reported: 0
| Name | Count (% of total reports) |
Diabetes Mellitus Non-insulin-dependent | 2 (100.00%) |
Treatment Noncompliance | 2 (100.00%) |
Nephrolithiasis | 2 (100.00%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports: